Show
Sort by
-
- Journal Article
- A1
- open access
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis : recruitment challenges, potential bias, and statistical strategies
-
- Journal Article
- A2
- open access
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis : results from the MSBase registry
-
- Journal Article
- A1
- open access
Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation
-
- Journal Article
- A1
- open access
Disability accrual in primary and secondary progressive multiple sclerosis
-
- Journal Article
- A1
- open access
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis
-
- Journal Article
- A1
- open access
Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis
-
- Journal Article
- A1
- open access
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
-
- Journal Article
- A1
- open access
Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis
-
Machine-learning-based prediction of disability progression in multiple sclerosis : an observational, international, multi-center study
-
- Journal Article
- A1
- open access
Comparing 16 different dual-tasking paradigms in individuals with multiple sclerosis and healthy controls : working memory tasks indicate cognitive-motor interference